drugset / Trial / NCT03050476
Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Study should demonstrate that alkaline phosphatase reduces the incidence and extent of acute kidney injury after cardiopulmonary bypass (CPB) as defined by the AKIN criteria.
Timeline
- Start
- 2017-11-01
- Primary completion
- 2025-09-30
- Completion
- 2026-03-31
Outcome
Missed primary endpoint
release “While these endpoints were not found for the total patient cohort in this phase IIb trial” alloksys.com ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RESCAP® | Unknown | 10000 iu | Intravenous |